Moderna, Inc. (MRNA)
USD 27.61
(2.15%)
USD 27.61
(2.15%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.15 Billion USD | -85.12% |
| 2022 | 13.84 Billion USD | -8.41% |
| 2021 | 15.11 Billion USD | 5571.96% |
| 2020 | 266.55 Million USD | 1466.6% |
| 2019 | 17.01 Million USD | 105.13% |
| 2018 | -331.57 Million USD | -311.95% |
| 2017 | 156.43 Million USD | 81.02% |
| 2016 | 86.42 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 35 Million USD | -98.14% |
| 2024 Q2 | 85 Million USD | 142.86% |
| 2023 Q4 | 1.88 Billion USD | 559.51% |
| 2023 FY | 2.06 Billion USD | -85.12% |
| 2023 Q2 | -387 Million USD | -136.17% |
| 2023 Q3 | -410 Million USD | -5.94% |
| 2023 Q1 | 1.07 Billion USD | -66.2% |
| 2022 Q2 | 3.18 Billion USD | -35.3% |
| 2022 Q4 | 3.16 Billion USD | 49.34% |
| 2022 FY | 13.84 Billion USD | -8.41% |
| 2022 Q1 | 4.92 Billion USD | -17.91% |
| 2022 Q3 | 2.12 Billion USD | -33.44% |
| 2021 Q1 | 1.55 Billion USD | 599.96% |
| 2021 FY | 15.11 Billion USD | 5571.96% |
| 2021 Q4 | 5.99 Billion USD | 46.02% |
| 2021 Q3 | 4.1 Billion USD | 18.53% |
| 2021 Q2 | 3.46 Billion USD | 123.55% |
| 2020 FY | 266.55 Million USD | 1466.6% |
| 2020 Q3 | -331.78 Million USD | -168.52% |
| 2020 Q4 | 221.44 Million USD | 166.74% |
| 2020 Q1 | -110.54 Million USD | -2.93% |
| 2020 Q2 | -123.55 Million USD | -11.77% |
| 2019 Q1 | -116.29 Million USD | 1.12% |
| 2019 Q4 | -107.4 Million USD | -1.04% |
| 2019 Q3 | -106.29 Million USD | 10.13% |
| 2019 Q2 | -118.27 Million USD | -1.7% |
| 2019 FY | 17.01 Million USD | 105.13% |
| 2018 Q3 | -72.38 Million USD | 7.96% |
| 2018 Q1 | -62.66 Million USD | -113.06% |
| 2018 FY | -331.57 Million USD | -311.95% |
| 2018 Q4 | -117.61 Million USD | -62.48% |
| 2018 Q2 | -78.64 Million USD | -25.51% |
| 2017 Q4 | -29.41 Million USD | 42.49% |
| 2017 Q3 | -51.14 Million USD | 19.83% |
| 2017 Q2 | -63.78 Million USD | 0.0% |
| 2017 Q1 | -63.78 Million USD | 0.0% |
| 2017 FY | 156.43 Million USD | 81.02% |
| 2016 FY | 86.42 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 4854.55% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 2130.663% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -10132.183% |
| Autolus Therapeutics plc | -4.86 Million USD | 44377.789% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 59662336.988% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 258183.832% |
| Shattuck Labs, Inc. | -2.38 Million USD | 90456.394% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 89630.536% |
| CervoMed Inc. | -1.29 Million USD | 166685.886% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 30460.665% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 7014.218% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 454219.209% |
| Precision BioSciences, Inc. | 40.47 Million USD | -5224.669% |
| Dyadic International, Inc. | 922.95 Thousand USD | -233388.667% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 3311.433% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 1466086.395% |
| Nektar Therapeutics | 53.47 Million USD | -3929.694% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -2075.91% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -508154.717% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -5107.075% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 504783.841% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -2175.055% |
| GRI Bio, Inc. | 10.84 Million USD | -19778.24% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -84742.987% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 24907.183% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 2221749.485% |
| Psyence Biomedical Ltd. | -240.00 USD | 897916766.667% |
| IGM Biosciences, Inc. | -211.66 Million USD | 1118.142% |
| INmune Bio, Inc. | 155 Thousand USD | -1390222.581% |
| Opthea Limited | 21.72 Thousand USD | -9921631.123% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -535969.652% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 3532.895% |
| Verastem, Inc. | -62 Thousand USD | 3475906.452% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -88401.027% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 825770.498% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -71092.6% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -1699.537% |
| NextCure, Inc. | -3.68 Million USD | 58596.2% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 16232.838% |
| Organovo Holdings, Inc. | -5.38 Million USD | 40088.866% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Arvinas, Inc. | 71.8 Million USD | -2901.393% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 178955.986% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -10647.058% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 262265.45% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -35423.405% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -1292.2% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 2294.121% |
| Senti Biosciences, Inc. | -2.68 Million USD | 80420.537% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -1477952.126% |
| Apollomics, Inc. | 127 Thousand USD | -1696750.394% |
| PureTech Health plc | -1.6 Million USD | 134535.434% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 7539.243% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -268603.242% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 2050.42% |
| Synaptogenix, Inc. | -6347.00 USD | 33953148.684% |
| ChromaDex Corporation | 50.78 Million USD | -4143.797% |
| Beam Therapeutics Inc. | -59.67 Million USD | 3711.409% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -1688.768% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 2021.345% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | -537.421% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 34524.92% |
| Mesoblast Limited | -9.81 Million USD | 22056.19% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -1493.122% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 2295.328% |
| MediWound Ltd. | 3.57 Million USD | -60129.178% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -1795733.333% |
| Fortress Biotech, Inc. | 57.85 Million USD | -3624.958% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -5011527.907% |
| Achilles Therapeutics plc | -4.73 Million USD | 45648.053% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -1615.478% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 5058.24% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 9369665.217% |
| Zai Lab Limited | 170.9 Million USD | -1160.949% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -26817.312% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -1657592.308% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -1111.736% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -13492.784% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 130.834% |
| FibroGen, Inc. | 128.9 Million USD | -1571.787% |
| Celcuity Inc. | -142.77 Thousand USD | 1509499.602% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| ContextLogic Inc. | 59 Million USD | -3552.542% |
| GH Research PLC | -315 Thousand USD | 684226.984% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -12899.94% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -553884.576% |
| ImmuCell Corporation | 4.39 Million USD | -48918.671% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | -506.453% |
| Amarin Corporation plc | 165.54 Million USD | -1201.792% |
| TG Therapeutics, Inc. | 219.1 Million USD | -883.533% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 380170.547% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 194594.585% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 2953.02% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -2835.847% |
| Aptorum Group Limited | -1.11 Million USD | 193427.64% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | -453.928% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | -559.524% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 3224844.49% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -795.175% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 417132.739% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 60787.13% |
| Ardelyx, Inc. | 106.66 Million USD | -1920.42% |
| Ainos, Inc. | -253.73 Thousand USD | 849417.984% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 4737.301% |
| Prothena Corporation plc | -129.2 Million USD | 1767.944% |
| HilleVax, Inc. | -2.15 Million USD | 100053.618% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -4173.764% |
| Celularity Inc. | 6.75 Million USD | -31802.295% |
| Rallybio Corporation | -150 Thousand USD | 1436766.667% |
| Cue Biopharma, Inc. | -32.6 Million USD | 6709.01% |
| Omeros Corporation | -69.77 Million USD | 3188.322% |
| Humacyte, Inc. | -76.55 Million USD | 2915.153% |
| Immunocore Holdings plc | 248.39 Million USD | -767.584% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 14306.606% |
| Blueprint Medicines Corporation | 236.58 Million USD | -810.882% |
| IO Biotech, Inc. | -756 Thousand USD | 285152.91% |
| MEI Pharma, Inc. | 49.32 Million USD | -4268.804% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 151222.02% |
| Summit Therapeutics Inc. | -2.05 Million USD | 105221.951% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 45014.548% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -7316.968% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 75873.558% |
| Pulmatrix, Inc. | -8.22 Million USD | 26316.545% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 184288.034% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 108065.932% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 540200.251% |
| Acelyrin, Inc. | -115 Thousand USD | 1874013.043% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 640.379% |
| Cytokinetics, Incorporated | -322.59 Million USD | 768.024% |
| Vor Biopharma Inc. | -3.49 Million USD | 61812.486% |
| Evogene Ltd. | 1.39 Million USD | -153938.599% |
| Replimune Group, Inc. | -2.65 Million USD | 81267.608% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 5007.542% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 3759301.758% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -31327.738% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| BioLineRx Ltd. | 1.1 Million USD | -194394.585% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 6530403.03% |
| Atai Life Sciences N.V. | -5000.00 USD | 43100100.0% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 2244891.667% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -434375.806% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 155247.588% |
| Sagimet Biosciences Inc. | 2 Million USD | -107650.0% |
| MediciNova, Inc. | 979.7 Thousand USD | -219864.173% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 2655.77% |
| MiMedx Group, Inc. | 266.84 Million USD | -707.591% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 2279196.822% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | -781.264% |
| PTC Therapeutics, Inc. | 872.33 Million USD | -147.038% |
| Mereo BioPharma Group plc | 7.42 Million USD | -28919.661% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 17958433.333% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 43100100.0% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 87666.03% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Allakos Inc. | -6.14 Million USD | 35192.005% |
| scPharmaceuticals Inc. | 9.78 Million USD | -21930.26% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 3223.369% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | -352.832% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 18890352.454% |
| Precigen, Inc. | 106 Thousand USD | -2032918.868% |
| XOMA Corporation | 3.86 Million USD | -55714.556% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 3174.838% |
| Incyte Corporation | 3.44 Billion USD | 37.366% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 4247242.294% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -14466.716% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -17195.345% |
| Seer, Inc. | 7.02 Million USD | -30567.426% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 240.95 Million USD | -794.354% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 7431134.483% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -16576922976.923% |
| Akari Therapeutics, Plc | -4000.00 USD | 53875100.0% |
| Novavax, Inc. | 639.93 Million USD | -236.752% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -1106685.546% |
| UroGen Pharma Ltd. | 73.35 Million USD | -2837.889% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 8172.975% |
| Entera Bio Ltd. | -56 Thousand USD | 3848314.286% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 1140311.64% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -53096.742% |
| Chimerix, Inc. | 324 Thousand USD | -665023.457% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 410576.19% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -418346.602% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 4876989.653% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 36.592% |
| AnaptysBio, Inc. | 14.78 Million USD | -14479.528% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -373915.714% |
| Portage Biotech Inc. | -54 Thousand USD | 3990840.741% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 571718.037% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 171539.936% |
| OKYO Pharma Limited | -7506.16 USD | 28709853.056% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 47942257.953% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 108838483.838% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 970720820.721% |
| AbCellera Biologics Inc. | 38.02 Million USD | -5567.324% |
| Genprex, Inc. | -15 Thousand USD | 14362936.577% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 322704.79% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 18890352.454% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| Daré Bioscience, Inc. | 2.76 Million USD | -77711.261% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 124738.519% |
| Bicycle Therapeutics plc | -129.52 Million USD | 1763.836% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 639.203% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -3701.51% |
| Erasca, Inc. | -3.73 Million USD | 57843.837% |
| bluebird bio, Inc. | -4.03 Million USD | 53573.945% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -213477.8% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | -13.161% |
| DBV Technologies S.A. | 15.72 Million USD | -13601.679% |
| Fortress Biotech, Inc. | 57.85 Million USD | -3624.958% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 1287.93% |
| CorMedix Inc. | -205.56 Thousand USD | 1048445.511% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -1510.757% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 377508.056% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -83621.834% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 5577.467% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 2039.205% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -8713.545% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 60161.315% |
| Onconetix, Inc. | -1.12 Million USD | 191287.626% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -11216.494% |
| Prime Medicine, Inc. | -147.9 Million USD | 1557.016% |
| Adagene Inc. | 18.11 Million USD | -11798.523% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -353758.785% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 1503927.608% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -1437.068% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 1344.313% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -1265.341% |
| SciSparc Ltd. | 2.19 Million USD | -98032.969% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 8603237.85% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 6955751.669% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -2136.219% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -3845.513% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 30427.953% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | -41.974% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -2092.536% |
| ADMA Biologics, Inc. | 88.21 Million USD | -2342.812% |
| Clene Inc. | 533 Thousand USD | -404215.197% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -8838.502% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 225282.863% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -108300.402% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 1109118.3% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -4226.875% |
| Absci Corporation | -41.84 Million USD | 5249.466% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 80.932% |
| Surrozen, Inc. | -27.23 Million USD | 8014.065% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 2877.133% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 4700.867% |
| Cingulate Inc. | -582.91 Thousand USD | 369791.792% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 6951712.903% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 28467735.403% |
| Jaguar Health, Inc. | 7.72 Million USD | -27800.052% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 244708.4% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | -216.583% |
| Kronos Bio, Inc. | 1.37 Million USD | -156969.971% |
| Innoviva, Inc. | 261.06 Million USD | -725.465% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 4115.578% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -7298.126% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 20721253.846% |
| Soligenix, Inc. | 97.31 Thousand USD | -2214449.229% |
| AlloVir, Inc. | -398 Thousand USD | 541557.286% |
| Century Therapeutics, Inc. | -10.8 Million USD | 20037.089% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 208917.829% |
| Kura Oncology, Inc. | -849 Thousand USD | 253928.033% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 1282838.095% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -3379.23% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 143166.645% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 332428.893% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 7361581.178% |
| HCW Biologics Inc. | -574.82 Thousand USD | 374997.36% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 2322.795% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 688598.403% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -2181.365% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 1232634.331% |
| Histogen Inc. | 3.76 Million USD | -57076.97% |
| Surrozen, Inc. | -27.23 Million USD | 8014.065% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 576303.209% |
| Kodiak Sciences Inc. | -25.94 Million USD | 8405.392% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 16377968.977% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 3210241.365% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 105530.528% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -336618.75% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | -176.809% |
| Turnstone Biologics Corp. | 16.5 Million USD | -12955.858% |
| Immix Biopharma, Inc. | -5468.00 USD | 39411219.239% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 4225590.196% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -1235.482% |
| Exelixis, Inc. | 1.75 Billion USD | -22.606% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 34735.166% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -1970.145% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Alkermes plc | 1.37 Billion USD | -56.764% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 194594.585% |
| Arcellx, Inc. | 108.27 Million USD | -1890.229% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 1818803.53% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -29347.933% |
| Insmed Incorporated | 239.63 Million USD | -799.284% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 6757.604% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -2620.822% |
| Moolec Science SA | -143.3 Thousand USD | 1503885.632% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 5192.396% |
| Geron Corporation | -123.5 Million USD | 1844.897% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -65461.302% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -49123.39% |
| Royalty Pharma plc | 1.79 Billion USD | -20.129% |
| OmniAb, Inc. | 14.66 Million USD | -14592.848% |
| Alector, Inc. | -95.05 Million USD | 2367.156% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 3174.618% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 2034.227% |
| Humacyte, Inc. | -76.55 Million USD | 2915.153% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 227139.51% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -2531.997% |
| 89bio, Inc. | -273 Thousand USD | 789477.289% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Aura Biosciences, Inc. | -1.29 Million USD | 166509.266% |
| Immunic, Inc. | -111 Thousand USD | 1941541.441% |
| Veracyte, Inc. | 248.14 Million USD | -768.433% |
| Genelux Corporation | -848 Thousand USD | 254227.358% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 1752132.52% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 382092298.582% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 18571.083% |
| Immunovant, Inc. | -231 Thousand USD | 933000.433% |
| Vericel Corporation | 135.57 Million USD | -1489.514% |
| Fortrea Holdings Inc. | 424 Million USD | -408.255% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 2600.957% |
| XBiotech Inc. | -1.74 Million USD | 123666.514% |
| Agenus Inc. | 139.61 Million USD | -1443.53% |
| Acasti Pharma Inc. | -11 Thousand USD | 19591009.091% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 53613.29% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 1053287.174% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 332428.893% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -12725.091% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 4440.645% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 19130.643% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 565716.798% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 9901.246% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -3063.256% |
| United Therapeutics Corporation | 2.07 Billion USD | -4.106% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -39907307.407% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 2609595.901% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -3252042.943% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 54767.016% |
| Pharming Group N.V. | 220.1 Million USD | -879.083% |
| XOMA Corporation | 3.86 Million USD | -55714.556% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | -434.44 Thousand USD | 496130.604% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 200751.769% |
| Pyxis Oncology, Inc. | -2 Million USD | 107850.0% |
| uniQure N.V. | 2.21 Million USD | -97191.196% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 113521.053% |
| Cassava Sciences, Inc. | -89.42 Million USD | 2509.895% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 975314.615% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 2628148.78% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 2440.636% |
| Pluri Inc. | 322 Thousand USD | -669154.658% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| MeiraGTx Holdings plc | 287 Thousand USD | -750771.08% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -3354.522% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 20731.966% |
| CalciMedica, Inc. | -58 Thousand USD | 3715617.241% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 7082.018% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | -495.255% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 21440752.671% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 200751.769% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -77541.29% |
| Nutriband Inc. | 862.1 Thousand USD | -249869.551% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 632064.809% |
| Compugen Ltd. | 31.45 Million USD | -6751.057% |
| Roivant Sciences Ltd. | 109.23 Million USD | -1872.811% |
| ProKidney Corp. | -3.16 Million USD | 68102.524% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 7637069.31% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -189838.127% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 2839.256% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 1768537.292% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -8690.178% |
| Benitec Biopharma Inc. | 108 Thousand USD | -1995270.37% |
| GeoVax Labs, Inc. | -20.72 Million USD | 10500.195% |
| Biomea Fusion, Inc. | -4.2 Million USD | 51397.31% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 695261.29% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 2921.678% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -908.258% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 9511.713% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 2762920.513% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 229111.69% |
| Imunon, Inc. | -720 Thousand USD | 299403.477% |
| BioAtla, Inc. | -103.73 Million USD | 2177.489% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 987.492% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 693026.045% |
| Zura Bio Limited | - USD | -Infinity% |
| aTyr Pharma, Inc. | -2.38 Million USD | 90342.881% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 409018.406% |
| Viridian Therapeutics, Inc. | -1 Million USD | 213889.683% |
| Galecto, Inc. | -830 Thousand USD | 259738.554% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | -238.362% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -192482.663% |
| PolyPid Ltd. | -1.82 Million USD | 118376.619% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 1811024.37% |
| Forte Biosciences, Inc. | -9000.00 USD | 23944544.444% |
| Xencor, Inc. | -85.26 Million USD | 2627.563% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 215333.971% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -1106685.546% |
| Instil Bio, Inc. | -4.75 Million USD | 45411.186% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 2279196.822% |
| OncoCyte Corporation | 413 Thousand USD | -521691.768% |
| Elevation Oncology, Inc. | -39 Thousand USD | 5525741.026% |
| Purple Biotech Ltd. | -196 Thousand USD | 1099589.796% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -23929.884% |
| MacroGenics, Inc. | 50.52 Million USD | -4165.046% |
| Verona Pharma plc | -679.62 Thousand USD | 317187.095% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 1231528.571% |
| Aditxt, Inc. | -111.66 Thousand USD | 1930065.968% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Savara Inc. | -44.26 Million USD | 4968.736% |
| Curis, Inc. | 9.81 Million USD | -21865.141% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 1727028.871% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 945275.439% |
| BeiGene, Ltd. | 2.07 Billion USD | -3.663% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 7637069.31% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 235619.126% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 45211.995% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 402152.239% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -1863.16% |
| Adicet Bio, Inc. | -6.09 Million USD | 35439.456% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -441498.361% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Generation Bio Co. | -73.91 Million USD | 3015.669% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 493235.011% |
| Invivyd, Inc. | -2.02 Million USD | 106362.327% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 816.325% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 2083473.615% |
| Moolec Science SA | -143.3 Thousand USD | 1503885.632% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -27278.986% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 43100100.0% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 257875.12% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -2483.468% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -2947432.553% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -3953.647% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 610581.586% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 11039.642% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 218217.409% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 3824955.348% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -9902.321% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | -587.023% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 738113.699% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 324648.193% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -53600.473% |
| ImmunityBio, Inc. | -17.89 Million USD | 12145.836% |
| Korro Bio, Inc. | -3.63 Million USD | 59466.391% |
| Kineta, Inc. | 5.43 Million USD | -39565.01% |
| BioVie Inc. | -229.37 Thousand USD | 939601.345% |
| Codexis, Inc. | 57.33 Million USD | -3658.677% |
| Celularity Inc. | 6.75 Million USD | -31802.295% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -4259635.126% |
| Cibus, Inc. | 1.42 Million USD | -151447.117% |
| Annexon, Inc. | -3.26 Million USD | 66062.657% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 5263.284% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -1145.989% |
| NeurAxis, Inc. | 2.15 Million USD | -99820.991% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 10288.162% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 114121.164% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -931224.036% |
| Notable Labs, Ltd. | 113 Thousand USD | -1906979.646% |
| IN8bio, Inc. | -2.5 Million USD | 86265.534% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 7183433.333% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -115635.768% |
| Lumos Pharma, Inc. | 2 Million USD | -107274.19% |
| Liquidia Corporation | 14.6 Million USD | -14660.274% |
| Mustang Bio, Inc. | -2.22 Million USD | 96953.933% |
| Quantum-Si incorporated | 488 Thousand USD | -441498.361% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 3978.76% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 1231528.571% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 10855.64% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 2039371.351% |
| Vaxcyte, Inc. | -75 Million USD | 2973.333% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 1386.475% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 179235.495% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -6706.964% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 110161.287% |
| PepGen Inc. | -1.18 Million USD | 182110.135% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 1696950.394% |
| Solid Biosciences Inc. | -76.56 Million USD | 2914.675% |
| Palisade Bio, Inc. | 246 Thousand USD | -875916.26% |
| Nutriband Inc. | 862.1 Thousand USD | -249869.551% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Immuneering Corporation | -764.13 Thousand USD | 282117.123% |
| Belite Bio, Inc | -399 Thousand USD | 540200.251% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 4831.273% |
| GeoVax Labs, Inc. | -20.72 Million USD | 10500.195% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 6530403.03% |
| Altimmune, Inc. | -65.37 Million USD | 3396.468% |
| Peak Bio, Inc. | 367.76 Thousand USD | -585865.647% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 493235.011% |
| Neurogene Inc. | -3.26 Million USD | 66163.765% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -1446.632% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 3918281.818% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 58469.447% |
| Sesen Bio, Inc. | 40 Million USD | -5287.5% |
| argenx SE | 1.1 Billion USD | -94.41% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 179235.495% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -87111.655% |
| Immunome, Inc. | -8.9 Million USD | 24294.454% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 528247.44% |
| Design Therapeutics, Inc. | -537 Thousand USD | 401403.538% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -100319.385% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 725689.226% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 22627.702% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -15205.398% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 80765.447% |
| Athira Pharma, Inc. | -969 Thousand USD | 222494.221% |
| XOMA Corporation | 3.86 Million USD | -55714.556% |
| Merus N.V. | -83.46 Million USD | 2682.044% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 669354.658% |
| Rezolute, Inc. | -36 Thousand USD | 5986211.111% |
| Clene Inc. | 533 Thousand USD | -404215.197% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 167834990.966% |
| BeyondSpring Inc. | 1.75 Million USD | -122972.53% |
| Synlogic, Inc. | -1.92 Million USD | 112106.237% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 5824424.324% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 34133.481% |
| Peak Bio, Inc. | 367.76 Thousand USD | -585865.647% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 11464.236% |
| Krystal Biotech, Inc. | 47.6 Million USD | -4426.835% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -1427.383% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -42785.572% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 83329.731% |
| MannKind Corporation | 136.19 Million USD | -1482.337% |
| Ikena Oncology, Inc. | -50.49 Million USD | 4368.003% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -1880.444% |
| Gossamer Bio, Inc. | -4.38 Million USD | 49244.812% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 855258.73% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 43100100.0% |
| Legend Biotech Corporation | 140.92 Million USD | -1429.139% |
| Mural Oncology plc | -2.56 Million USD | 84050.136% |
| Disc Medicine, Inc. | -100 Thousand USD | 2155100.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -10283.541% |
| REGENXBIO Inc. | 53.02 Million USD | -3963.814% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 40328.092% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 1120307.927% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 124522.633% |
| Vaxart, Inc. | -60.76 Million USD | 3646.566% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 820177.631% |
| Cellectis S.A. | 18 Thousand USD | -11972122.222% |
| Longeveron Inc. | 221 Thousand USD | -975013.122% |
| Repare Therapeutics Inc. | -80.07 Million USD | 2791.395% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | -97.165% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 166637.867% |
| Revolution Medicines, Inc. | -399.66 Million USD | 639.203% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 6157242.857% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -4397859.184% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 74.962% |
| Denali Therapeutics Inc. | -93.34 Million USD | 2408.64% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 8603237.85% |
| Veru Inc. | 7.56 Million USD | -28382.957% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 1427252.318% |
| Cingulate Inc. | -582.91 Thousand USD | 369791.792% |
| Passage Bio, Inc. | -3.72 Million USD | 58014.539% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 17892826.669% |
| Exicure, Inc. | -1.42 Million USD | 151540.618% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 562763.185% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -79626.23% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 420444.273% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 1440540.621% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 3739.834% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -551050.895% |
| OmniAb, Inc. | 14.66 Million USD | -14592.848% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -10678.773% |
| Lipocine Inc. | -2.85 Million USD | 75692.339% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 117028.92% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 37873.883% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 143166.645% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -2761.278% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 3315484.615% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -2456.468% |
| Ocugen, Inc. | -33.53 Million USD | 6525.739% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 68253.068% |
| Q32 Bio Inc. | 578 Thousand USD | -372737.37% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 813307.547% |
| Alumis Inc. Common Stock | -1.28 Million USD | 167934.891% |
| Equillium, Inc. | 35.95 Million USD | -5893.103% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 126344.874% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -430315.496% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 52128788.921% |
| Dominari Holdings Inc. | 2.03 Million USD | -105589.063% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 1174672.548% |
| vTv Therapeutics Inc. | -13.59 Million USD | 15951.416% |
| Bio-Techne Corporation | 773.07 Million USD | -178.757% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -12342.982% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | -367.679% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 184445.595% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 9086.656% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -18323.527% |
| Nkarta, Inc. | -5.86 Million USD | 36818.351% |
| BioCardia, Inc. | -7.24 Million USD | 29828.238% |
| Iterum Therapeutics plc | -1.75 Million USD | 123242.857% |